Fecal occult blood test screening for colorectal cancer

Gastrointestinal Endoscopy Clinics of North America

Volumn 12, Issue 1, 2002, Pages 11-21

  Bond, John H ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVICE; DIAGNOSTIC ACCURACY; FECES ANALYSIS; HUMAN; INTESTINE POLYP; OCCULT BLOOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SIGMOIDOSCOPY; TREATMENT INDICATION;

EID: 0036144767     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5157(03)00054-0     Document Type: Review

References (39)

1. Accuracy of fecal occult blood screening for colorectal neoplasia: A prospective study using Hemoccult and HemoQuant tests
2. A comparison of fecal occult blood tests for colorectal cancer screening
3. The findings and impact of nonrehydrated guaiac examination of the Rectum (FIINGER) study: A comparison of 2 methods of screening for colorectal cancer in asymptomatic average-risk patients
4. Are fecal occult blood testing and flexible sigmoidoscopy adequate for colorectal cancer screening?
5. Colorectal cancer update: Prevention, screening, treatment, and surveillance for high-risk groups
6. Fecal occult blood testing for colorectal cancer
7. Polyp guideline: Diagnosis, treatment, and surveillance for patients with colorectal polyps
8. Fecal occult screening in the Minnesota Study: Sensitivity of the screening test
9. Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions
10. Outpatient screening for gastrointestinal lesions using guaiacimpregnated slides
11. Diagnosis of large bowel cancer in the asymptomatic patient
12. Occult blood testing for detection of asymptomatic colon cancer
13. Randomized controlled trial of faecal occult blood screening for colorectal cancer
14. Randomized controlled trial of faecal occult blood screening for colorectal cancer: Results of first 107,349 subjects
15. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps
16. Value of retesting subjects with a positive Hemoccult in screening for colorectal cancer
17. Randomized study of screening for colorectal cancer with faecal occult blood test
18. Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colonoscopy?
19. Colorectal cancer screening: Recommendations of the U.S. Preventive Services Task Force
20. Screening for colorectal cancer: A comparison of 3 fecal occult blood tests
21. Cost-effectiveness model for colon cancer screening
22. Use of colonoscopy to screen asymptomatic adults for colorectal cancer
23. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers: The University of Minnesota's Colon Cancer Control Study
24. Reducing mortality from colorectal cancer by screening for fecal occult blood
25. Colorectal cancer mortality: The effectiveness of biennial screening for fecal occult blood
26. The effect of fecal occult-blood screening on the incidence of colorectal cancer
27. Immunochemical versus guaiac occult blood stool tests: Results of a community based screening program
28. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
29. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice
30. Effect of fecal occult blood testing on mortality from colorectal cancer: A case-control study
31. American Cancer Society guidelines for the early detection of cancer: Update of early detection guidelines for prostate, colorectal, and endometrial cancers
32. Hemoccult stool tests: False-negative results due to storage of specimens
33. The cost effectiveness of colorectal cancer screening in average risk adults
34. Effectiveness of colorectal cancer screening: Results from a population-based case-control evaluation in Saarland, Germany
35. Fecal occult blood test screening trials
36. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy
37. Colorectal cancer screening: Clinical guidelines and rationale
38. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy